PTH and chronic kidney disease: Preclinical and clinical studies demonstrate that Etel reduces bone turnover and cortical porosity(Ct.Po) improving trabecular bone structure in CKD-SHPT patients via PTH suppression (Khairallah et al., 2023; Li et al., 2017; Ruderman et al., 2020; Shigematsu et al., 2018).